Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Women with PCOS have more emotional and body image issues than healthy women.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

People undergoing chemotherapy need better support and information to cope with hair loss.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The revised Chinese Symptom Checklist-90 is more reliable and valid for psychological assessments.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

The new system helps detect and track early female hair loss better.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.